Showing results (121-130 of 1,629) with videos related to
Sort By:
Pageof 163
Expert Review of Clinical Pharmacology|August 31, 2016
Cardiovascular adverse events by non-steroidal anti-inflammatory drugs: when the benefits outweigh the risksGerhard Zingler, Birgit Hermann, Tim Fischer, et al.Expert Review of Clinical Pharmacology|December 7, 2013
Therapeutic options in pulmonary hepatic vascular diseasesThomas Horvatits, Valentin FuhrmannExpert Review of Clinical Pharmacology|December 7, 2013
Canagliflozin versus glimepiride treatment in patients with type 2 diabetes inadequately controlled with metformin (CANTATA-SU trial)Stephen N DavisExpert Review of Clinical Pharmacology|December 7, 2013
Non-benzodiazepine hypnotics and older adults: what are we learning about zolpidem?Hedva B LevyExpert Review of Clinical Pharmacology|December 12, 2013
The genetics of vascular incidents associated with second-generation antipsychotic administrationEnrico Cocchi, Antonio Drago, Diana de Ronchi, et al.Expert Review of Clinical Pharmacology|November 26, 2011
Methylphenidate transdermal system: clinical applications for attention-deficit/hyperactivity disorderJosephine Elia, Zoe Wilson, Lilly Sehgal La Porta, et al.Expert Review of Clinical Pharmacology|November 26, 2011
Recent advances in medicines for children and neonatesImti ChoonaraExpert Review of Clinical Pharmacology|November 26, 2011
Anti-inflammatory drugs as moderators of antidepressant effects, especially those of the selective serotonin-reuptake inhibitor classSefi KronenbergExpert Review of Clinical Pharmacology|November 26, 2011
Overcoming immunogenicity associated with the use of biopharmaceuticalsMichael G Tovey, Julie Legrand, Christophe LallemandExpert Review of Clinical Pharmacology|November 25, 2011
Long-acting muscarinic antagonists for the treatment of chronic obstructive pulmonary diseaseDramane I LainéPageof 163